James Pallotta
Founder, Managing Partner @ Raptor Group
Great Falls, United States
James Pallotta is a seed investor at Raptor Group in Great Falls focused on Software and Mobile. James Pallotta is the founder of ShareNett. He previously worked at Tudor Investment Corporation as a Vice-Chairman. James attended Northeastern University.
- Total investments:
- 35
- Last investment:
- Lead investor:
- 9%
Last updated:
For AI agents: llms.txt
Industries James Pallotta invests in
Stages James Pallotta invests in
Countries James Pallotta invests in
Round sizes
Round size
- Seed
- $365k–$2.5M
- Series A
- $5M–$28M
Investment Focus
Industry
- Software 12 (34%)
- Mobile 7 (20%)
- SaaS 6 (17%)
- FinTech 5 (14%)
- Advertising 5 (14%)
Stage
- Seed 16 (46%)
- Series A 10 (29%)
- Funding Round 3 (9%)
- Angel 2 (6%)
- Venture - Series Unknown 2 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Language I/O
|
The future of translation is conversational and Language I/O’s proprietary machine translation optimization technology ensures that every conversation is understood. Their machine translation optimizer can translate difficult to translate user-generated content such as jargon, slang, abbreviations, and misspellings in 150 languages over chat,email, article, and social support channels.Language I/O seamlessly integrates within all major CRMs and also provides an API. Finally, we let customers decide whether to use professional human linguists, our machine translation optimizer, or a combination of the two. | $6.5M / Series A / Jan 11, 2022 | |
Swiftline
|
Swiftline propel e-commerce sellers through integrated, data science-backed products and services. | $12M / Series A / Dec 01, 2021 | |
qolo
|
Qolo is a B2B payment hub that allows businesses to manage payments and reduced expense. The company was founded in 2018 by experts and entrepreneurs in payments. It is headquartered in Fort Lauderdale, Florida, United States. | $15M / Series A / Aug 25, 2021 | |
ImaginAb
|
ImaginAb is a biotechnology company focused on developing a new class of highly targeted diagnostic imaging agents based on engineered antibody fragments. ImaginAb's platform technology enables the rapid engineering of antibodies into fragments that retain the parental antibody but are immunologically passive and kinetically-optimized forclinical imaging. This combination of superior specificity and kinetics enables ImaginAb to generate agents that can address the unmet needs in diagnosis and patient selection for therapeutics. | $12.8M / Venture - Series Unknown / Jun 03, 2021 | |
Pipe
|
Pipe operates a global trading platform for recurring revenue streams, connecting companies to institutional investors to trade in real time. It makes recurring revenue streams tradable for their annual value offering more cash flow for scaling companies | $50M / Venture - Series Unknown / Mar 09, 2021 | |
HALO Diagnostics
|
At HALO Diagnostics (HALO Dx), we recognize every patient is unique. Our focus is early detection and precision-focused healthcare, preventing, and conquering diseases that have a geometric impact on patient outcomes. We accomplish this with a personalized diagnostic ensemble including advanced imaging, genomics, non-invasive liquid biomarkertests, and community-based data at scale combined with deep learning algorithms. By optimizing these solutions under the HALO Dx platform, we provide precise, actionable results to enable life-changing treatments by physicians for their patients. | $19M / Series A / Mar 04, 2021 | |
|
HALO Diagnostics
|
At HALO Diagnostics (HALO Dx), we recognize every patient is unique. Our focus is early detection and precision-focused healthcare, preventing, and conquering diseases that have a geometric impact on patient outcomes. We accomplish this with a personalized diagnostic ensemble including advanced imaging, genomics, non-invasive liquid biomarkertests, and community-based data at scale combined with deep learning algorithms. By optimizing these solutions under the HALO Dx platform, we provide precise, actionable results to enable life-changing treatments by physicians for their patients. | $19M / Series B / Mar 04, 2021 | |
|
ImaginAb
|
ImaginAb is a biotechnology company focused on developing a new class of highly targeted diagnostic imaging agents based on engineered antibody fragments. ImaginAb's platform technology enables the rapid engineering of antibodies into fragments that retain the parental antibody but are immunologically passive and kinetically-optimized forclinical imaging. This combination of superior specificity and kinetics enables ImaginAb to generate agents that can address the unmet needs in diagnosis and patient selection for therapeutics. | $8M / Sep 14, 2017 | |
IdeaFlow
|
IdeaFlow is a startup from MIT that came out of research working to extend the human mind into the computer. Its core product is a shared brain for organizations, a human-AI hybrid Web platform that enables teams of analysts to collaboratively create, visualize, and analyze networks of information, both manually and by integrating previouslystagnant data sources. The company was founded in 2015 and is headquartered in Palo Alto, California. | $1.8M / Seed / Dec 01, 2015 | |
Paxos
|
Paxos is a regulated financial institution building infrastructure to enable movement between physical and digital assets.The company takes a two-pronged approach of establishing regulatory designations that give it access to the current financial infrastructure and the ability to develop innovative products. This allows Paxos to operate as agateway between traditional finance and the digital future. Paxos was founded in 2012 and headquartered in New York, United States. | $28.2M / Series A / May 08, 2015 | |
| See all 35 investments → | |||
Co-Investors
About Raptor Group
Raptor Group Holdings is an alternative investment firm that provides investment management and advisory services. Raptor Group sources and invest in companies across various stages and asset classes, ranging from early-stage venture to both private and public equity. Raptor focuses on various industries including, but not limited to Sports,Consumer, Technology, Media, Entertainment, and Financial Services. It was founded in 2009 and headquartered in Boston, Massachusetts.
Raptor Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
James Pallotta
Founder, Managing Partner
|
|||
|
James Pallotta
Founder, Managing Partner
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does James Pallotta invest in?
James Pallotta invests primarily in Software, Mobile and SaaS startups, most often at Seed and Series A stage. Most of the 35 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is James Pallotta's check size?
James Pallotta typically joins rounds of $365k–$2.5M at Seed and $5M–$28M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds James Pallotta participates in.
When did James Pallotta last invest?
The most recent investment recorded for James Pallotta closed in Jan 2022. Shizune tracks 35 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
